Clinical Trial Update: Study Evaluating Pantoprazole in Adolescents With GERD [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating pantoprazole in adolescents with gastroesophageal reflux disease has completed. Sponsor Wyeth is now part of Pfizer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• Pantoprazole (pantoprazole)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Gastroesophageal Reflux | Phase 3 | Status: COMPLETED